Using of methylphenidate and risperidone in a case with Joubert's syndrome with comorbid disruptive behavior disorders

Volume: 10 Number: 3 October 1, 2017
Mutlu Karakuş , Canan İnce , Zehra Merve Karadeniz , Büşra Duran , Sema Kandil
PDF Download
Pamukkale Medical Journal Cover Pamukkale Medical Journal
TR EN

Yıkıcı davranım bozukluklarının eşlik ettiği Joubert sendromlu bir olguda metilfenidat ve risperidon kullanımı

Abstract

Joubert sendromu molar diş görünümü ile karakterize nadir bir orta beyin-beyin malformasyonu bozukluğudur. Posterior interpedinküler fossa derinliğinde artma, süperior serebellar pedinküllerde kalınlaşma ve vermis hipoplazisi bu sendromda görülen bulgulardır.Serebeller bozukluklar şiozfreni, bipolar bozukluk, depresyon, anksiyete, dikkat eksikliği hiperaktivite bozukluğu (DEHB) gibi birçok psikiyatrik bozukluğa neden olabilmektedir. Bir çok çalışmada DEHB' nda serebellumda değişiklikler gösterilmiştir. DEHB ile serbellum ve posterior fossa volumleri arasında ilişki gösteren çalışmalar da mevcuttur. Bu olguda Joubert sendromunda DEHB, davranım bozukluğu ve mental retardasyon etyolojik mekanizmaları ve tedavileri açısından tartışılması amaçlanmıştır.

Keywords

Joubert sendromu, DEHB, mental retardasyon, davranış bozukluğu, tedavi

References

  1. No references found

Details

Primary Language

English

Subjects

-

Journal Section

-

Authors

Mutlu Karakuş This is me

Canan İnce This is me

Zehra Merve Karadeniz This is me

Büşra Duran This is me

Sema Kandil This is me

Publication Date

October 1, 2017

Submission Date

October 1, 2017

Acceptance Date

-

Published in Issue

Year 2017 Volume: 10 Number: 3

IZ

https://izlik.org/JA68PR67AN

Cite

RIS / Bibtex
APA
Karakuş, M., İnce, C., Karadeniz, Z. M., Duran, B., & Kandil, S. (2017). Using of methylphenidate and risperidone in a case with Joubert’s syndrome with comorbid disruptive behavior disorders. Pamukkale Medical Journal, 10(3), 278-281. https://izlik.org/JA68PR67AN
AMA
1.Karakuş M, İnce C, Karadeniz ZM, Duran B, Kandil S. Using of methylphenidate and risperidone in a case with Joubert’s syndrome with comorbid disruptive behavior disorders. Pam Med J. 2017;10(3):278-281. https://izlik.org/JA68PR67AN
Chicago
Karakuş, Mutlu, Canan İnce, Zehra Merve Karadeniz, Büşra Duran, and Sema Kandil. 2017. “Using of Methylphenidate and Risperidone in a Case With Joubert’s Syndrome With Comorbid Disruptive Behavior Disorders”. Pamukkale Medical Journal 10 (3): 278-81. https://izlik.org/JA68PR67AN.
EndNote
Karakuş M, İnce C, Karadeniz ZM, Duran B, Kandil S (October 1, 2017) Using of methylphenidate and risperidone in a case with Joubert’s syndrome with comorbid disruptive behavior disorders. Pamukkale Medical Journal 10 3 278–281.
IEEE
[1]M. Karakuş, C. İnce, Z. M. Karadeniz, B. Duran, and S. Kandil, “Using of methylphenidate and risperidone in a case with Joubert’s syndrome with comorbid disruptive behavior disorders”, Pam Med J, vol. 10, no. 3, pp. 278–281, Oct. 2017, [Online]. Available: https://izlik.org/JA68PR67AN
ISNAD
Karakuş, Mutlu - İnce, Canan - Karadeniz, Zehra Merve - Duran, Büşra - Kandil, Sema. “Using of Methylphenidate and Risperidone in a Case With Joubert’s Syndrome With Comorbid Disruptive Behavior Disorders”. Pamukkale Medical Journal 10/3 (October 1, 2017): 278-281. https://izlik.org/JA68PR67AN.
JAMA
1.Karakuş M, İnce C, Karadeniz ZM, Duran B, Kandil S. Using of methylphenidate and risperidone in a case with Joubert’s syndrome with comorbid disruptive behavior disorders. Pam Med J. 2017;10:278–281.
MLA
Karakuş, Mutlu, et al. “Using of Methylphenidate and Risperidone in a Case With Joubert’s Syndrome With Comorbid Disruptive Behavior Disorders”. Pamukkale Medical Journal, vol. 10, no. 3, Oct. 2017, pp. 278-81, https://izlik.org/JA68PR67AN.
Vancouver
1.Mutlu Karakuş, Canan İnce, Zehra Merve Karadeniz, Büşra Duran, Sema Kandil. Using of methylphenidate and risperidone in a case with Joubert’s syndrome with comorbid disruptive behavior disorders. Pam Med J [Internet]. 2017 Oct. 1;10(3):278-81. Available from: https://izlik.org/JA68PR67AN

Creative Commons Lisansı

Pamukkale Medical Journal is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY NC).